AIM ImmunoTech (AIM) Research & Development (2010 - 2026)
AIM ImmunoTech (AIM) recorded Research & Development of $589,000 in Q2 2026, down 49.8% from $1.17 million a year earlier but up 22.2% from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Research & Development (2010 - 2026) Analysis & Trends
On a TTM basis, AIM ImmunoTech's Research & Development came in at $2.74 million as of Jun 30, 2026, down 48.8% year-over-year; for FY2025, it came in at $3.92 million, down 36.7% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of -7.3% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $6.2 million in FY2024 (-43.3%), $10.94 million in FY2023 (+56.5%), $6.99 million in FY2022 (-8.9%) and $7.67 million in FY2021 (+34.1%).
- Quarterly Research & Development has ranged from $482,000 in Q1 2026 to $3.2 million in Q4 2023 over the past five years.
- On a year-over-year basis, Research & Development has declined for four consecutive quarters, with an average decline of 42.1% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 99.3% in Q3 2023, against a decline of 61.2% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $482,000 (Q1 2026), $1.06 million (Q4 2025) and $607,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | 589,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 589,000.00 |
| Mar 31, 2026 | 482,000.00 |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 607,000.00 |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 1.95 Mn |
| Dec 31, 2023 | 3.20 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 2.95 Mn |
| Mar 31, 2023 | 2.05 Mn |
| Dec 31, 2022 | 2.11 Mn |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 2.48 Mn |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 2.92 Mn |
| Sep 30, 2021 | 2.01 Mn |
API Access
AIM ImmunoTech Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();